Rho GTPases as therapeutic targets for the treatment of inflammatory diseases

Author： Zhao Dezheng Pothoulakis Charalabos

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.7, Iss.5, 2003-10, pp. : 583-592

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Implication of Rho GTPases in Neurodegenerative Diseases

Current Drug Targets, Vol. 12, Iss. 8, 2011-07 ,pp. : 1202-1215

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Therapeutic Targets for Somatostatin in Inflammatory Chronic Diseases

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 4, Iss. 1, 2005-02 ,pp. : 91-104

Bentham Science Publishers

Access to resources Recommend Favorite

Cytokines in inflammatory diseases: role and therapeutic targets in acute respiratory distress syndrome

By Shanley T.P.

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 2, 1998-12 ,pp. : 1-16

Informa Healthcare

Access to resources Recommend Favorite

Rho GTPases: Promising Cellular Targets for Novel Anticancer Drugs

Current Cancer Drug Targets, Vol. 6, Iss. 1, 2006-02 ,pp. : 1-14

Bentham Science Publishers

Access to resources Recommend Favorite

Selectins as Targets in Inflammatory Diseases

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 3, Iss. 1, 2004-03 ,pp. : 31-38

Bentham Science Publishers

Access to resources Recommend Favorite